Benefits Overview Enrollment & Participation Engagement & Persistence Clinical Outcomes Clinical Pathway Medical Utilization Program Performance Member Experience Engagement & Outcomes

Benefits Intelligence · Benefits Director

Clinical Outcomes

Weight change, blood pressure, HbA1c, BMI, and A1C impact — all in privacy-safe aggregate form.

Privacy: no group under 11 shownSample data

Weight loss ≥5%

61%

achieved meaningful loss

Measured

6-month persistence

79%

remain on treatment

Observed

Meaningful actions / week

2.8

per active member

Observed

Timely follow-up

80%

258 of 323 cases

Observed

Measured

61%

Weight loss ≥5%

n = 1,285

45% benchmark

Measured

-9.9%

Avg weight change

from baseline

-5.2% benchmark

Measured

8 mmHg

Systolic BP drop

average reduction

4 mmHg benchmark

Measured

0.5%

HbA1c reduction

average reduction

0.3% benchmark

A1C Impact & Value

— what happens when A1C drops, and what it’s worth

Average HbA1c · Last 12 months

8.2%

Baseline

7.7%

After 12 months

−0.5 pp

reduction

Clinical target: <7.0%0.7 pp above target

Diabetic-range members

874

of 1,285 with follow-up

A1C improved

629

72% of diabetics

Clinical risk reduction

UKPDS-based

Each 1 percentage-point A1C drop reduces complication risk. At −0.5 pp:

Microvascular complications (kidney, eye, nerve)−18.5%

Per 1 pp drop: −37%

Diabetes-related mortality−10.5%

Per 1 pp drop: −21%

Heart attack−7.0%

Per 1 pp drop: −14%

Stroke−6.0%

Per 1 pp drop: −12%

A1C distribution shift

n = 874

Members moving from uncontrolled toward controlled range:

Controlled (<7.0%)15% → 38%

Uncontrolled (7.0–8.9%)55% → 47%

Very uncontrolled (≥9.0%)30% → 15%

Before After

Financial value of A1C reduction

Modeled

Annual cost avoidance per improved member

Hospitalizations avoided

$1,500

ER visits avoided

$350

Medication optimization

$550

Absenteeism (2 fewer days)

$620

Total per member / year$3,020

Total value · 12 months

$1.90M

Medical cost avoidance$1.51M

Productivity recovery$390K

Based on 629 members with A1C improvement. Modeled, not realized — see Financial Impact for validation status.

Weight loss distribution

n = 1,285

≥10% weight loss308 (24%)

5–10% weight loss475 (37%)

<5% weight loss360 (28%)

No change / gained141 (11%)

BMI change & data completeness

Average BMI

33.8 → 30.5

among 643 members with paired measurements

Follow-up measurement coverage

Weight

638/83976%

Blood pressure

579/83969%

HbA1c

403/83948%

Lipids

445/83953%

All outcomes are measured from paired baseline and follow-up values. Benchmarks are illustrative, not validated external data. Clinical outcomes are shown only in properly aggregated, privacy-safe form.

Employee Privacy Protected by Design

Employer reporting is designed to present aggregate workforce and health-program insights without exposing individual clinical records. Small-group reporting restrictions help reduce the risk of employee identification.

Sample dataPrivacy-restricted reporting

Aggregated information is not described as HIPAA-de-identified unless applicable de-identification requirements have been satisfied and verified.